logo

For the Inventor, By the Inventor

KR

Aprogen Inc.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 60.0



Trademarks = 4

Forward Citations = 7

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Gou Young Koh (5 out of 15 patents)

silverMedal Chung-Hyun Cho (3 out of 3 patents)

bronzeMedal Sangsoon Yoon (2 out of 9 patents)

4.  Mee Sook Oh (2 out of 2 patents)

5.  Hyo Jeong Hong (2 out of 13 patents)

6.  Keun Soo Kim (2 out of 25 patents)

7.  Kwon Pyo Hong (1 out of 5 patents)

8.  Yoo Ri Moon (1 out of 7 patents)

9.  Jeong Won Hong (1 out of 3 patents)

10.  Da Bin Choi (1 out of 2 patents)

11.  David S Wilson, Jr (1 out of 8 patents)

12.  Cheol-Young Maeng (1 out of 7 patents)

13.  George Kopsidas (1 out of 8 patents)

14.  Irene Koukoulas (1 out of 2 patents)

15.  Vincent Batori (1 out of 4 patents)


10 patents:

1. 11820831 - Antibody binding to carbonic anhydrase and use thereof (2023-11-21),
2. 11542339 - Anti-CD43 antibody and use thereof for cancer treatment (2023-01-03),
3. 10259860 - Fusion proteins binding to VEGF and angiopoietin (2019-04-16),
4. 8426570 - Recombinant expression vector for animal cell (2013-04-23),
5. 8420353 - Humanized antibody and process for preparing same (2013-04-16),
6. 8414877 - Method for inducing angiogenesis in an infarcted heart by administering a coiled coil chimeric molecule (2013-04-09),
7. 8268316 - Monoclonal antibody specific to anthrax toxin (2012-09-18),
8. 8206698 - Method of treating a cutaneous wound using a coiled coil chimeric molecule (2012-06-26),
9. 7691366 - Chimeric CMP-Ang1 molecule (2010-04-06),
10. 7691365 - Methods of using chimeric coiled coil molecule to treat ischemic disease (2010-04-06),
Company Overview
Aprogen Inc. is a biotechnology company based in South Korea, specializing in the development and manufacturing of innovative biopharmaceuticals. The organization focuses on advanced therapeutic solutions, particularly in the fields of monoclonal antibodies and biosimilars, aiming to address unmet medical needs. With a commitment to research and development, Aprogen leverages cutting-edge technologies to enhance drug efficacy and safety, contributing to the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#33 in

#1,094 in South Korea

#56,119 in the World

KR
KR

Aprogen Inc.

Forward Citations = 7

35 inventors:

goldMedal Gou Young Koh (5 out of 15 patents)

silverMedal Chung-Hyun Cho (3 out of 3 patents)

bronzeMedal Sangsoon Yoon (2 out of 9 patents)

4.  Mee Sook Oh (2 out of 2 patents)

5.  Hyo Jeong Hong (2 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aprogen Inc.. Retrieved from https://idiyas.com/company/aprogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…